title: Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.
abstract: Cognitive impairment is common also in early stages of MS, but only little is known about its relationship to standard immunotherapeutic drugs. Present data suggest that both immunosuppressive as well as immunomodulatory therapy prevent or delay the onset and severity of cognitive impairment although reversible cognitive deficits can occur.
authors.affiliation: Neurologische Klinik, Universität Ulm, Rehabilitationskrankenhaus, Oberer Eselsberg 45, 89081, Ulm, Germany. hayrettin.tumani@uni-ulm.de
authors.forename: Hayrettin
authors.initials: H
authors.lastname: Tumani
authors.forename: Ingo
authors.initials: I
authors.lastname: Uttner
mesh_terms: D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016899:Interferon-beta / Q000378:metabolism; D009103:Multiple Sclerosis / Q000150:complications* / Q000276:immunology
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016899:Interferon-beta